Nutraceuticals for Metabolic Syndrome Management: From Laboratory to Benchside

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|12|4|565-571

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.12, Iss.4, 2014-01, pp. : 565-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nutraceuticals for Treatment of High Blood Pressure Values in Patients with Metabolic Syndrome

By Rozza Francesco  

High Blood Pressure & Cardiovascular Prevention, Vol. 16, Iss. 4, 2009-12 ,pp. : 177-182

Adis International

Access to resources Recommend Favorite

Management of Cardiovascular Risk Factors in Patients with Metabolic Syndrome

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 3, 2007-07 ,pp. : 209-214

Bentham Science Publishers

Access to resources Recommend Favorite

Thiazolidinediones for the Therapeutic Management of Polycystic Ovary Syndrome: Impact on Metabolic and Reproductive Abnormalities

By Elkind-Hirsch Karen E.  

Treatments in Endocrinology, Vol. 5, Iss. 3, 2006-01 ,pp. : 171-187

Adis International

Access to resources Recommend Favorite

Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects

By Nardo L. G.   Rai R.  

Gynecological Endocrinology, Vol. 15, Iss. 5, 2001-10 ,pp. : 373-380

Informa Healthcare

Access to resources Recommend Favorite

Acquired von Willebrand Syndrome: Its Pathophysiology, Laboratory Features and Management

By Mohri Hiroshi  

Journal of Thrombosis and Thrombolysis, Vol. 15, Iss. 3, 2003-06 ,pp. : 141-149

Springer Publishing Company

Access to resources Recommend Favorite